Berlin - Delayed Quote • EUR Isoray Inc (AAJ.BE) Follow 1.4700 -0.0800 (-5.16%) At close: April 26 at 8:08 AM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for AAJ.BE 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: AAJ.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Perspective Therapeutics to Participate at Upcoming April Investor Conferences Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024 Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility Perspective Therapeutics Announces $87.4 Million Private Placement Perspective Therapeutics to Participate at Upcoming Investor Conferences These Drug Companies Are Going Nuclear to Fight Cancer PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference Related Tickers TIVC Tivic Health Systems, Inc. 1.0400 -3.70% CATX Perspective Therapeutics, Inc. 1.5800 -1.25% ELUT Elutia Inc. 2.7800 -6.40% NVCR NovoCure Limited 12.64 +3.31% BJDX Bluejay Diagnostics, Inc. 0.6419 +16.50%
